生物
可药性
分子内力
RNA剪接
选择性拼接
计算生物学
细胞生物学
遗传学
基因
基因亚型
立体化学
核糖核酸
化学
作者
Uris Ros,Veronica Martinez-Osorio,Pedro Alberto Valiente,Yasmin Abdelwahab,Miloš Gojković,Raed Shalaby,Silvia Zanna,Julia Saggau,Laurens Wachsmuth,Harshal Nemade,Jonathan Zoeller,Hannah Sophia Lottermoser,Yuguang Chen,M. K. A. IBRAHIM,Konstantinos Kelepouras,Lazaros Vasilikos,Paula Bedoya,Rafael Atillo Espiritu,Stefan Müller,Veronika Altmannová
出处
期刊:Molecular Cell
[Elsevier BV]
日期:2025-04-01
卷期号:85 (8): 1589-1605.e12
被引量:16
标识
DOI:10.1016/j.molcel.2025.03.015
摘要
Necroptosis is an inflammatory form of regulated cell death implicated in a range of human pathologies, whose execution depends on the poorly understood pseudokinase mixed lineage kinase domain-like (MLKL). Here, we report that splicing-dependent insertion of a short amino acid sequence in the C-terminal α-helix (Hc) of MLKL abolishes cell killing activity and creates an anti-necroptotic isoform that counteracts cell death induced by the necroptosis-proficient protein in mice and humans. We show that interaction of Hc with a previously unrecognized hydrophobic groove is essential for necroptosis, which we exploited in a strategy to identify small molecules that inhibit MLKL and substantially ameliorate disease in murine models of necroptosis-driven dermatitis and abdominal aortic aneurysm. Thus, alternative splicing of microexons controls the ability of MLKL to undergo an intramolecular rearrangement essential for necroptosis with potential to guide the development of allosteric MLKL inhibitors for the treatment of human disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI